ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Gene therapy – affordability, access and reimbursement
Brian Huber considers the affordability, access and reimbursement challenges within the gene therapy market.
How CRO venture capital relationships can help biotech fundraising
This article considers how partnering with a CRO can help emerging biotechs to secure funding.
The personalised medicine paradigm
Cindy Spittle shares insights on the growth of molecular diagnostic testing in clinical trials.
Estimands: bringing clarity and focus to research questions in clinical trials
ICON's biostatistics experts offer their insights on the role of estimands in clinical research.
Sharing clinical trial results with paediatric participants
Kirsten Sherman Cervati contributes to this media article which discusses the considerations for returning results to paediatric participants.
Resisting change: The pathway to better AMR planning
Caroline Forkin, Vice President for Clinical Research Services, offers her insights on the various actions that should be taken to improve AMR planning.
In-Home Services: A patient-centric approach to improving recruitment and retention in clinical trials
An interview with Jodie Huddleston, Vice President Accellacare In-Home Services on the use of hybrid and decentralised models as viable solutions in clinical trial design.
Decentralised trials dramatically transforming clinical research: ICON
Isaac Rodriguez-Chavez discusses the impact decentralised trials have had on the industry, and how that transformation is likely to continue.
Capture, curate, consume: The three Cs of managing data in decentralised and hybrid clinical trials
Emily Mitchell and Christina Dinger run through some of the most important elements of collating and organising data during clinical trials.
Combating antimicrobial resistance
Shelley McLendon, Vice President, Vaccines and Infectious Disease, discusses the use of novel diagnostics to help monitor for AMR outbreaks and reduce the overuse and misuse of antimicrobials.